Martin J Driscoll Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Martin J Driscoll.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Martin J Driscoll. Martin J Driscoll is a Director in GENTA INC DE/ ($GNTA) and a in MetaStat, Inc. ($MTST) and a President and CEO in Spring Bank Pharmaceuticals, Inc. ($SBPH).
Address: TWO CONNELL DRIVE BERKELEY HEIGHTS 07922 NJ
Companies in which Martin J Driscoll is an Insider
F-star Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Martin J Driscoll: President and CEO
Holdings: 90,400 shares
Current Value: $678,000
Latest Transaction: Mar 09 2020
$SBPH Market Capitalization: $58.25M
$SBPH Previous Close: $7.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GENTA INC DE/
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Martin J Driscoll: Director
Holdings: 15,000 shares
Latest Transaction: May 15 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MetaStat, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Martin J Driscoll:
Holdings: 49,616 shares
Current Value: $76,905
Latest Transaction: Apr 06 2017
$MTST Market Capitalization: $7.06M
$MTST Previous Close: $1.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Martin J Driscoll
Sentiment: All, SBPH, GNTA, MTST
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 09 2020 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
| Mar 09 2020 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Option Exercise | A | 1.41 | 40,000 | 56,400 | 40,000 | |
| Nov 14 2019 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 2.83 | 5,000 | 14,150 | 90,400 | 85.4 K to 90.4 K (+5.85 %) |
| May 29 2019 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 6.03 | 10,000 | 60,300 | 85,400 | 75.4 K to 85.4 K (+13.26 %) |
| May 22 2019 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 6.63 | 5,000 | 33,150 | 75,400 | 70.4 K to 75.4 K (+7.10 %) |
| Apr 30 2019 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 7.36 | 5,000 | 36,800 | 70,400 | 65.4 K to 70.4 K (+7.65 %) |
| Apr 30 2019 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 7.31 | 5,000 | 36,550 | 65,400 | 60.4 K to 65.4 K (+8.28 %) |